Orion Oyj (OTCMKTS:ORINF) Sees Large Growth in Short Interest

Orion Oyj (OTCMKTS:ORINF) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totalling 381,700 shares, a growth of 21.8% from the July 15th total of 313,300 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 3,817.0 days.

Orion Oyj Price Performance

Shares of OTCMKTS:ORINF remained flat at $47.16 during trading on Friday. The business’s 50-day moving average is $47.16 and its 200-day moving average is $47.16. Orion Oyj has a 52-week low of $47.16 and a 52-week high of $47.16.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.